Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs

Abstract

The authors review the FDA policies and procedures that permit some patients with serious conditions to receive investigational drugs before formal product approval and examine the legal and ethical issues associated with expanded access.